From: An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma
Characteristics | Number of patients, n (%) | |
---|---|---|
 | Frozen tissues (n=20) | FFPE tissues (n=21) |
Age (median, range) | 58 (41-76) years | 55 (31-86) years |
Menopausal status | Â | Â |
Pre-menopausal | 5 (25%) | 4 (19%) |
Post-menopausal | 15 (75%) | 17 (81%) |
Type | Â | Â |
IDC | 19 (95%) | 21 (100%) |
DCIS | 1 (5%) | 0 (0%) |
ER status | Â | Â |
Positive | 16 (80%) | 14 (67%) |
Negative | 4 (20%) | 7 (33%) |
PR status | Â | Â |
Positive | 14 (70%) | 12 (57%) |
Negative | 6 (30%) | 9 (43%) |
HER2 score | Â | Â |
0, 1+, 2+ | 19 (95%) | 4 (19%) |
3+ | 1 (5%) | 17 (81%) |